Skip to main content

In practice

Neuer Inhalt Free Registration

Gain full access to the latest clinical content available from Springer Nature

Patient and physician's perspectives

20-04-2017 | Esophageal cancer | Patient and physician’s perspective | Article

Oesophageal adenocarcinoma: A patient and physician’s perspective

This article is co-authored by a patient with oesophageal adenocarcinoma and his physician, who performed oesophagectomy.

Maule D, Boccola M, & Lord RV. Oncol Ther 2017. doi:10.1007/s40487-017-0044-4

01-07-2016 | Colorectal cancer | Patient and physician’s perspective | Article

Living with cancer: Through the eyes of the patient and the physician

A patient describes his experience of diagnosis and treatment for adenocarcinoma of the colon. This commentary is accompanied by a physician’s perspective of the management steps taken to tackle this patient’s condition.

Vigo JM et al. Oncol Ther 2016; 4: 183–187. doi:10.1007/s40487-016-0025-z

Practical management guides

Case reports

14-03-2017 | Lymphoma | Case report | Article


A 72-year-old man with a history of diabetes mellitus, hypertension, and hypercholesterolemia self-palpated a left submandibular lump – read how the City of Hope team approached his case.

In: Management of Lymphomas: A Case-Based Approach. Edited by Zain J & Kwak LW. Springer International Publishing, 2017. doi:10.1007/978-3-319-26827-9_4

09-03-2017 | Lymphoma | Case report | Article

CNS lymphoma

This  case report describes the presentation, workup and staging, and treatment recommendations for a 56-year-old woman who presented with vertigo, headaches, and frequent falls.

In: Management of Lymphomas: A Case-Based Approach. Edited by Zain J & Kwak LW. Springer International Publishing, 2017. doi:10.1007/978-3-319-26827-9_14

09-03-2017 | Lymphoma | Case report | Article

Cutaneous T-cell lymphoma

In this case report, an 83-year-old female presented to the physician with a progressing pruritic cutaneous rash that started 8 years ago. Read this review to understand how her condition was managed.

In: Management of Lymphomas: A Case-Based Approach. Edited by Zain J & Kwak LW. Springer International Publishing, 2017. doi:10.1007/978-3-319-26827-9_10

Publish your case report with Medicine Matters oncology

We welcome all well-described case reports of educational value that make a contribution to medical knowledge.

Related content

15-09-2017 | Renal cell carcinoma | Article

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma

This study shows that disease symptoms reduce health-related quality of life (HRQoL) in renal cell carcinoma, suggesting that targeted therapies that increase progression-free survival should postpone reductions in HRQoL.

de Groot S et al. Qual Life Res 2017. doi:10.1007/s11136-017-1704-4

01-09-2017 | Neuroendocrine tumors | Article

Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30

In this study, the authors find peptide receptor radionuclide therapy to be effective in the treatment of pancreatic neuroendocrine tumors whilst also improving the quality of life of patients.

Marinova M, et al. Eur J Nucl Med Mol Imaging 2017. doi:10.1007/s00259-017-3816-z

22-08-2017 | Brain metastases | Article

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy

This study found that one in four breast cancer patients with brain metastases could not be discharged from hospital following whole brain radiotherapy (WBRT), suggesting some overtreatment in late palliative stages.

Frisk G, et al. Breast Cancer Res Treat 2017. doi:10.1007/s10549-017-4466-3

02-08-2017 | Lymphoma | Article

Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen

This study investigates the effect of palonosetron on delayed chemotherapy-induced nausea and vomiting in non-Hogkin’s lymphoma patients receiving cyclophosphamide, doxorubicin, vincristine and prednisone.

Saito B, Nakashima H, Abe M et al. Support Care Cancer 2017. doi:10.1007/s00520-017-3845-y

28-09-2017 | Palliative care | News

Lorazepam reduces agitation in haloperidol-treated advanced cancer patients

Lorazepam significantly reduces the intensity of agitation, compared with placebo, in advanced cancer patients with agitated delirium despite already receiving scheduled haloperidol, US study data show.


JAMA 2017; 318: 1014–1015, 1047–1056

18-09-2017 | Pancreatic cancer | Article

What questions are most important to pancreatic cancer patients soon after diagnosis? A multicenter survey

Surveying patients diagnosed with pancreatic cancer in the Netherlands, the authors explore the wide range of questions patients consider most important to address in the weeks following their diagnosis.

Ronde-Schoone LJM et al. Appl Cancer Res 2017; 37: 32. doi:10.1186/s41241-017-0038-4

image credits